|
TLK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64390723256247E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20320420293751E-11 |
| Normal-vs-Stage2 |
1.442200E-04 |
| Normal-vs-Stage3 |
3.67483821150927E-14 |
| Normal-vs-Stage4 |
2.99760216648792E-15 |
| Stage1-vs-Stage2 |
8.045700E-02 |
| Stage1-vs-Stage3 |
6.099800E-02 |
| Stage1-vs-Stage4 |
1.017450E-03 |
| Stage2-vs-Stage3 |
3.281400E-03 |
| Stage2-vs-Stage4 |
2.834400E-04 |
| Stage3-vs-Stage4 |
1.896640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88737914186277E-14 |
| Normal-vs-AfricanAmerican |
2.598900E-04 |
| Normal-vs-Asian |
2.87769996720755E-09 |
| Caucasian-vs-AfricanAmerican |
1.835200E-01 |
| Caucasian-vs-Asian |
7.457600E-01 |
| AfricanAmerican-vs-Asian |
3.007800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06880060357639E-11 |
| Normal-vs-Female |
1.74804615227231E-12 |
| Male-vs-Female |
8.512200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.9101945559803E-11 |
| Normal-vs-Age(41-60Yrs) |
1.0350054147068E-11 |
| Normal-vs-Age(61-80Yrs) |
8.3686391150195E-12 |
| Normal-vs-Age(81-100Yrs) |
5.50999999999746E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.793000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.650200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.046600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.212600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.535200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.156400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.421200E-04 |
| Classical-VS-Follicular |
4.591600E-01 |
| Classical-VS-Other |
5.705400E-01 |
| Classical-VS-Normal |
1.9382273563906E-12 |
| Tall-VS-Follicular |
1.099800E-03 |
| Tall-VS-Other |
3.312800E-01 |
| Tall-VS-Normal |
3.32178728967847E-13 |
| Follicular-VS-Other |
5.035400E-01 |
| Follicular-VS-Normal |
1.36090000002476E-06 |
| Other-VS-Normal |
1.539920E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.57940360579323E-11 |
| Normal-vs-N1 |
3.0053737276603E-12 |
| N0-vs-N1 |
2.963500E-02 |
|
|
